Internal Server Error

CorMedix - About the company

CorMedix is a public company based in Bridgewater (United States), founded in 2006. It operates as a Commercial stage biopharma company with focus on cardiac, renal and infectious diseases. CorMedix has raised $2.62M in funding.

Company Details

CorMedix Inc. is a commercial-stage biopharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases. Its first product Neutrolin provides a preventative solution, which decreases the triple threat of infection, thrombosis and biofilm formation thereby keeping catheters operating safely and efficiently by optimizing catheter blood flow while minimizing infections and biofilm formation for oncology, hemodialysis, and intensive care patients. Neutrolin is CE approved in europe and company plans to expand distribution in USA, middle east, south america and africa
Social
X
Key Metrics
Founded Year
2006
Location
Bridgewater, United States
Stage
Public
Total Funding
$2.62M in 3 rounds
Annual Revenue
$100M - $500M as on Dec 31, 2025
Employee Count
185 as on Sep 30, 2026
Investment & Acquisitions
Exit Details
Public

CorMedix's IPO details

CorMedix got listed on Mar 25, 2010.
Click here to take a look at CorMedix's IPO in detail
Sign up to download CorMedix's company profile

CorMedix's funding and investors

CorMedix has raised a total funding of $2.62M over 3 rounds. Its first funding round was on Nov 12, 2009. Its latest funding round was a Grant (prize money) round on Aug 15, 2017 for $*****. 1 investor participated in its latest round. CorMedix has 2 institutional investors.

Here is the list of recent funding rounds of CorMedix:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Aug 15, 2017
3530945
Grant (prize money)
6549498
7155689
2702210
8618687
Oct 20, 2013
2089090
Post IPO
8488124
3071100
7261579
8624777
Nov 12, 2009
3599414
Seed
6632701
5112904
4444978
6954286
lockAccess funding benchmarks and valuations. Sign up today!

CorMedix's founders and board of directors

Founder? Claim Profile

CorMedix's employee count trend

CorMedix has 185 employees as of Sep 26. Here is CorMedix's employee count trend over the years:
Employee count trend for CorMedix
lockUncover CorMedix's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

CorMedix's Investments and acquisitions

CorMedix has made 1 investment in Talphera and acquired Melinta Therapeutics and Melinta Therapeutics.
Here is the list of these investments and acquisitions:
Date of Investment/Acquisition
Type
Company Name
Founded Year
Location
Sep 08, 2025
Investments
2005
San Mateo (United States)
Aug 07, 2025
Acquisition
2000
Morristown (United States)
2020
Acquisition
2000
Morristown (United States)
lockWant to know more about where corporates are investing? Sign up today!

Reports related to CorMedix

Here is the latest report on CorMedix's sector:

News related to CorMedix

lockFilter this list
Media has covered CorMedix for a total of 14 events in the last 1 year, 5 of them have been about company updates and 1 about people movement.
•
CorMedix (NASDAQ:CRMD) Price Target Raised to $15.00MarketBeat•Apr 28, 2026•CorMedix
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about CorMedix

Explore our recently published companies
  • Lacy And Par - Tukwila based, 1984 founded, Unfunded company
  • Moeheat - Santa Clarita based, 2008 founded, Public company
  • Z-axis Prints - Spokane based, 2010 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford